Lapaquistat Uses, Dosage, Side Effects and more
Lapaquistat is under investigation in clinical trial NCT00256178 (Efficacy of Lapaquistat Acetate and Simvastatin in Subjects With Primary Dyslipidemia.).
Trade Name | Lapaquistat |
Generic | Lapaquistat |
Lapaquistat Other Names | Lapaquistat |
Type | |
Formula | C31H39ClN2O8 |
Weight | Average: 603.11 Monoisotopic: 602.2394939 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |